The urinalysis market was valued at $3.1 billion in 2023, and is projected to reach $6.8 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033.
Urinalysis is a series of test that involves the examination of urine to detect and manage a wide range of disorders, such as urinary tract infections, diabetes, and kidney diseases. It encompasses both physical and chemical examinations of urine, as well as microscopic analysis of its cellular and particulate components. By analyzing the physical, chemical, and microscopic properties of urine, healthcare providers can assess urine color, clarity, and odor, which can provide initial clues about metabolic disorders.
The growth of the global urinalysis market is majorly driven by high incidence of urinary tract infections (UTIs), especially among women and the elderly, and increase in cases of kidney disorders. According to the National Institute of Health - world's foremost medical research centers - the number of UTI cases increased by 60.40% from 252.25 million in 1990 to 404.61 million in 2019, and this number is expected to increase significantly in the coming future. Furthermore, as per a study published in March 2024 by Lancet - one of the world's highest-impact academic journals - more than 850 million individuals are suffering from kidney disease globally. Moreover, alarming rise in prevalence of diabetes necessitate regular urinalysis for early detection and management, which acts as a key driving force of the global market. In addition, surge in geriatric population notably contributes toward the growth of the market. This is attributed to the fact that the aging population is highly susceptible to various urinary and renal conditions, leading to increased utilization of urinalysis in geriatric healthcare. However, high cost associated with urinalysis hampers the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, integration of AI and ML in digital urinalysis systems is expected to offer remunerative opportunities for the expansion of the market during the forecast period.
The global urinalysis industry segmented into by product, end user, and region. By product, the market is divided into instruments, and consumables. On the basis of application, it is fragmented into disease screening, and pregnancy & fertility testing. Depending on end user, it is segregated into hospitals, clinical laboratories, and home care. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of application, the disease screening segment exhibited the highest market share in 2023.
Depending on end user, the clinical laboratories segment was the major shareholder in 2023.
Region wise, the market in North America is anticipated to lead the market by 2033.
Urinalysis is a series of test that involves the examination of urine to detect and manage a wide range of disorders, such as urinary tract infections, diabetes, and kidney diseases. It encompasses both physical and chemical examinations of urine, as well as microscopic analysis of its cellular and particulate components. By analyzing the physical, chemical, and microscopic properties of urine, healthcare providers can assess urine color, clarity, and odor, which can provide initial clues about metabolic disorders.
The growth of the global urinalysis market is majorly driven by high incidence of urinary tract infections (UTIs), especially among women and the elderly, and increase in cases of kidney disorders. According to the National Institute of Health - world's foremost medical research centers - the number of UTI cases increased by 60.40% from 252.25 million in 1990 to 404.61 million in 2019, and this number is expected to increase significantly in the coming future. Furthermore, as per a study published in March 2024 by Lancet - one of the world's highest-impact academic journals - more than 850 million individuals are suffering from kidney disease globally. Moreover, alarming rise in prevalence of diabetes necessitate regular urinalysis for early detection and management, which acts as a key driving force of the global market. In addition, surge in geriatric population notably contributes toward the growth of the market. This is attributed to the fact that the aging population is highly susceptible to various urinary and renal conditions, leading to increased utilization of urinalysis in geriatric healthcare. However, high cost associated with urinalysis hampers the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, integration of AI and ML in digital urinalysis systems is expected to offer remunerative opportunities for the expansion of the market during the forecast period.
The global urinalysis industry segmented into by product, end user, and region. By product, the market is divided into instruments, and consumables. On the basis of application, it is fragmented into disease screening, and pregnancy & fertility testing. Depending on end user, it is segregated into hospitals, clinical laboratories, and home care. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the consumable segment dominated the market share in 2023.On the basis of application, the disease screening segment exhibited the highest market share in 2023.
Depending on end user, the clinical laboratories segment was the major shareholder in 2023.
Region wise, the market in North America is anticipated to lead the market by 2033.
Competition Analysis
Competitive analysis and profiles of the major players in the global urinalysis market include Abbott Laboratories, Sysmex Corporation, Siemens Healthcare GmbH, ACON Laboratories, Inc., Arkray Inc, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to capture maximum share and sustain the intense competition.Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Instruments
- Consumables
By Application
- Disease Screening
- Pregnancy Fertility Testing
By End User
- Hospitals
- Clinical Laboratories
- Home Care
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Sysmex Corporation
- Siemens Healthcare GmbH
- ACON Laboratories, Inc.
- Arkray Inc
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: URINALYSIS MARKET, BY PRODUCT
CHAPTER 5: URINALYSIS MARKET, BY APPLICATION
CHAPTER 6: URINALYSIS MARKET, BY END USER
CHAPTER 7: URINALYSIS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Key Market Players in the Urinalysis Market include:- Abbott Laboratories
- Sysmex Corporation
- Siemens Healthcare GmbH
- ACON Laboratories, Inc.
- Arkray Inc
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 3.1 billion |
| Forecasted Market Value ( USD | $ 6.8 billion |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
